Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLI400 vs Lubiprostone in Constipated Adults
NCT02481947Phase 3Completed
- Sponsor
- Braintree Laboratories
- Start
- May 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lactitol in chronic idiopathic constipation (CIC) (2 arms), sponsored by Braintree Laboratories. Primary endpoint: Complete Spontaneous Bowel Movement Response at 12 weeks. Started May 2015; status: completed.
02
Drugs
lactitol
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT02481947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481947.